• Treatment failure, readmissions, and poor outcomes are prevalent in ABSSSI: one study reported combined 30-day readmission and mortality rates at 12% for community-acquired infections, and 26% for healthcareassociated infections 3 • Specifically, evidence has been found regarding the association between obesity and ABSSSI treatment failure/ recurrent infections 4, 5 • However, the association between obesity and long-term clinical outcomes in ABSSSI patients is not well-studied
ObjECTIvE
• To assess the association of obesity with 30-day hospital readmission rates among ABSSSI patients
METHOdS

Data source
• Cerner Health Facts database
• This is a de-identified EMR database containing information from over 1,000 hospitals and for over 35,000,000 patients
• The essential data elements include longitudinal data for each patient, which contains patient demographic information (e.g., age, gender, and body mass index [BMI])
• For each admission, the data include diagnosis codes (ICD-9), DRGs, microbiology information, admission date, and discharge date • Proportion of patients with all-cause and ABSSSI-related readmission were compared between obese and non-obese cohorts descriptively overall and in subgroups defined by gender, age, and causative pathogen
• Multivariable logistic regression models were fitted to assess association of all-cause or ABSSSI-related 30-day readmission rates and obesity when adjusting for hospital size, demographics, insurance type, causative pathogen and comorbidities (congestive heart failure, peripheral vascular disorders, hypertension, chronic pulmonary disease, diabetes, renal failure, cancer, deficiency anemia, drug abuse, and depression)
Sample selection
Patients ( 
RESUlTS
Patient characteristics (Table 1) • Males formed a lower proportion of obese patients compared to non-obese patients (47.8% vs 55.8%, p<0.0001)
• A significantly lower percent of obese patients were ≥ 65 years compared to non-obese patients (28.2% vs 34.3%, p<0.0001); while the mean age was comparable between the two cohorts (54.5 vs 55.2, p=0.0884)
• The percent of patients with MRSA as the causative pathogen was lower in obese patients compared to non-obese patients (8.4% vs 10.6%, p=0.0001)
• More obese patients tended to have combined (abscess and cellulitis) infection (74.1% vs 70.4%, p<0.0001); but fewer obese patients tended to have cellulitis only infection (2.2% vs 3.6%, p<0.0001)
• Obese patients were more likely to have certain comorbidities including congestive heart failure, hypertension, chronic pulmonary disease, diabetes, hypothyroidism, renal failure, and depression Hospital characteristics (Table 2) • Obese and non-obese patients tended to be admitted to hospitals with comparable number of beds, and located in similar census regions
• A slightly lower percent of obese patients were admitted to teaching hospitals compared to non-obese patients (70.7% vs 73.4%, p=0.0009) 30-Day readmission rates (Table 3) • Same-hospital readmission rates within 30 days were higher for obese patients for both all-cause (12.9% vs 11.8%, p=0.0850) and ABSSSI-related (5.3% vs 4.0%, p=0.0019) readmission rates. Non-ABSSSI-related readmission rates were similar (7.6% vs 7.8%, p=0.7427)
• When stratified by gender, obese patients continued to have a higher ABSSSI-related 30-day readmission rate than non-obese patients (5.1% vs 3.8%, p=0.0086) in the male subgroup
• Obese patients in the younger age group (< 65 years) had a lower ABSSSI-related 30-day readmission rate than non-obese patients (5.0% vs 3.6%, p=0.0026) [a] 30-day readmission is defined as any inpatient stay of at least 12 hours that occurred within 30 days of the index admission discharge date.
[b] Includes admissions with both primary and non-primary diagnoses of ABSSSI.
Regression on readmission (Table 4) • After adjusting for hospital size, demographics, insurance type, causative pathogen, and comorbidities, the multivariable logistic regression showed that obese patients have higher odds of 30-day all-cause readmission compared to non-obese patients (OR=1.10, p=0.0944, 95% CI: 0.98, 1.24)
• Obese patients also had significantly higher odds of 30-day ABSSSI-related readmission compared to non-obese patients (OR=1.28, p=0.0073, 95% CI: 1.07, 1.54) [a] Odds ratios and p-values were estimated from the multivariate logistic regression adjusting for hospital type (number of beds), demographics (age, gender, and race), insurance type, causative pathogen, and selected comorbidities (congestive heart failure, peripheral vascular disorders, hypertension, chronic pulmonary disease, diabetes, renal failure, cancer, deficiency anemia, drug abuse, and depression).
dISCUSSIOn
• Among ABSSSI patients, obese patients experienced significantly higher rates of same-hospital ABSSSI-related readmission compared with non-obese patients in the overall population
• In subgroup analyses, obese patients experienced significantly higher rates of same-hospital ABSSSI-related readmission compared with non-obese patients among male patients and patients less than 65 years old. The differences were not significant among females and patients >65 years old
• The odds of ABSSSI-related readmission within 30 days was significantly higher for obese ABSSSI patients compared to non-obese patients when adjusting for hospital type, demographics, insurance type, causative pathogen, and selected comorbidities
